|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Spruce Biosciences, Inc. (SPRB) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
37,357,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing therapies for rare endocrine disorders with unmet medical need. Co. is developing its wholly-owned product candidate, tildacerfont, as a non-steroidal therapy to provide improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia and polycystic ovary syndrome.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,838,400 |
| Total Buy Value |
$0 |
$0 |
$0 |
$8,997,728 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
4,172,336 |
4,172,336 |
4,172,336 |
4,172,336 |
| Total Sell Value |
$3,408,657 |
$3,408,657 |
$3,408,657 |
$3,408,657 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
5 |
5 |
5 |
5 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Novo A/s |
10% Owner |
– – • |
2024-03-21 |
4 |
S |
$0.75 |
$350,951 |
D/D |
(465,021) |
2,550,000 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2024-03-20 |
4 |
S |
$0.73 |
$264,081 |
D/D |
(359,979) |
3,015,021 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2024-03-19 |
4 |
S |
$0.76 |
$447,715 |
D/D |
(593,000) |
3,375,000 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2024-03-18 |
4 |
S |
$0.77 |
$647,008 |
D/D |
(842,020) |
3,968,000 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2024-03-14 |
4 |
S |
$0.89 |
$1,698,902 |
D/D |
(1,912,316) |
4,810,020 |
|
- |
|
| Gharib Samir M. |
President & CFO |
• – – |
2023-12-29 |
4 |
A |
$0.98 |
$11,002 |
D/D |
11,255 |
202,776 |
|
- |
|
| Charlton Ralph William Iii |
Chief Medical Officer |
• – – |
2023-12-29 |
4 |
A |
$0.98 |
$9,150 |
D/D |
9,361 |
55,373 |
|
- |
|
| Szwarcberg Javier B. |
Chief Executive Officer |
• • – |
2023-12-15 |
4 |
D |
$1.66 |
$63,717 |
D/D |
(38,384) |
107,321 |
|
- |
|
| Szwarcberg Javier B. |
Chief Executive Officer |
• • – |
2023-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
111,000 |
145,705 |
|
- |
|
| Gharib Samir M. |
President & CFO |
• – – |
2023-12-15 |
4 |
D |
$1.66 |
$59,918 |
D/D |
(36,095) |
191,521 |
|
- |
|
| Gharib Samir M. |
President & CFO |
• – – |
2023-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
112,250 |
204,403 |
|
- |
|
| Charlton Ralph William Iii |
Chief Medical Officer |
• – – |
2023-12-15 |
4 |
D |
$1.66 |
$18,227 |
D/D |
(10,980) |
46,012 |
|
- |
|
| Charlton Ralph William Iii |
Chief Medical Officer |
• – – |
2023-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,750 |
56,992 |
|
- |
|
| Szwarcberg Javier B. |
Chief Executive Officer |
• • – |
2023-06-30 |
4 |
A |
$0.98 |
$19,550 |
D/D |
20,000 |
34,705 |
|
- |
|
| Charlton Ralph William Iii |
Chief Medical Officer |
• – – |
2023-06-30 |
4 |
A |
$0.98 |
$12,099 |
D/D |
12,378 |
25,242 |
|
- |
|
| Gharib Samir M. |
President & CFO |
• – – |
2023-06-30 |
4 |
D |
$2.15 |
$55,762 |
D/D |
(25,936) |
115,366 |
|
- |
|
| Gharib Samir M. |
President & CFO |
• – – |
2023-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
75,000 |
141,302 |
|
- |
|
| Gharib Samir M. |
President & CFO |
• – – |
2023-06-30 |
4 |
A |
$0.98 |
$10,248 |
D/D |
10,484 |
66,302 |
|
- |
|
| Odonnell Niall |
Director |
– • – |
2023-02-16 |
4 |
B |
$3.17 |
$1,998,368 |
I/I |
630,400 |
1,326,305 |
2.1 |
- |
|
| Novo A/s |
10% Owner |
– – • |
2023-02-16 |
4 |
B |
$3.17 |
$6,999,360 |
D/D |
2,208,000 |
6,722,336 |
2.45 |
- |
|
| Gharib Samir M. |
President & CFO |
• – – |
2023-01-03 |
4 |
D |
$1.15 |
$17,587 |
D/D |
(15,293) |
55,818 |
|
- |
|
| Gharib Samir M. |
President & CFO |
• – – |
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
71,111 |
|
- |
|
| Gharib Samir M. |
President & CFO |
• – – |
2022-12-30 |
4 |
A |
$0.93 |
$1 |
D/D |
1 |
33,611 |
|
- |
|
| Charlton Ralph William Iii |
Chief Medical Officer |
• – – |
2022-12-30 |
4 |
A |
$0.93 |
$12,000 |
D/D |
12,864 |
12,864 |
|
- |
|
| Szwarcberg Javier B. |
Chief Executive Officer |
• • – |
2022-12-30 |
4 |
A |
$0.93 |
$13,717 |
D/D |
14,705 |
14,705 |
|
- |
|
52 Records found
|
|
Page 1 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
